Back
Navient Corp. 10K Form
Sell
21
NAVI
Navient Corp.
Last Price:
$10.05
Seasonality Move:
-0.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-24 | 10Q | NAVI/Navient Corp. Quarterly |
| 2023-10-25 | 10Q | NAVI/Navient Corp. Quarterly |
| 2023-07-26 | 10Q | NAVI/Navient Corp. Quarterly |
| 2023-04-26 | 10Q | NAVI/Navient Corp. Quarterly |
| 2022-10-26 | 10Q | NAVI/Navient Corp. Quarterly |
| 2022-07-27 | 10Q | NAVI/Navient Corp. Quarterly |
Receive NAVI News And Ratings
See the #1 stock for the next 7 days that we like better than NAVI
NAVI Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $70M |
| Price / Cash Flow: | 4.47 |
| Annual Sales: | $24.48 |
| Price / Book: | 0.4 |
Profitability
| EPS (TTM): | -0.81860 |
|---|---|
| Net Income (TTM): | $-79M |
| Gross Margin: | $2.8B |
| Return on Equity: | -3.13% |
| Return on Assets: | -0.16% |
Navient Corp. Earnings Forecast
Key Navient Corp. Financial Ratios
-
The Gross Profit Margin over the past 23 years for NAVI is 86.96%.
-
The Selling, General & Administrative Expenses for NAVI have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of NAVI is -2.48% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 12 years.
Navient Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Consumer Finance |
| Sector: | Financials |
| Current Symbol: | NAVI |
| CUSIP: | 63938C |
| Website: | navient.com |
Debt
| Debt-to-Equity Ratio: | 19.05 |
|---|---|
| Current Ratio: | 0.41 |
| Quick Ratio: | 0.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.2 |
|---|---|
| Forward P/E Ratio: | 9.66 |
NAVI Technical Analysis vs Fundamental Analysis
Sell
21
Navient Corp. (NAVI)
is a Sell
Is Navient Corp. a Buy or a Sell?
-
Navient Corp. stock is rated a SellThe current Navient Corp. [NAVI] share price is $10.05. The Score for NAVI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.